Willowbrook, IL – According to filings with the U.S. Securities and Exchange Commission, Pharmazz is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Anil Gulati played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Pharmazz

Pharmazz, Inc. is a clinical stage pharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target critical care medicine. The company is developing several clinical-stage product candidates, PMZ-2010, PMZ-1620 and PMZ-2123 for which it holds global marketing rights. Established in 2010, Pharmazz, Inc. is an emerging global pharmaceutical company. Focus of the company is to discover, acquire, develop and market novel pharmaceutical products for use in critical care and hospital settings.

To learn more about Pharmazz, visit http://pharmazz.com/

Contact:
Anil Gulati, President and Chief Executive Officer
630-780-6087
https://www.linkedin.com/in/anil-gulati-86765822/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved